TruCheck™ Early Cancer Screening
Helping to detect cancer in its early stages can lead to a more effective and swifter treatment.
Revolutionising cancer detection with a single, convenient screening blood test, over 70 types of cancer can be recognised by TruCheck™; The early cancer screening blood test can detect cancers such as Adrenal Cancer, Biliary Tract Cancer, Bladder Cancer, Breast Cancer, CNS Cancer, Gastro-Intestinal Cancer, Gynaecological Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Male Cancers including Prostate Cancer, Melanoma, Mesothelioma, Salivary Gland Cancer, Soft Tissue Cancer and Osteosarcomas, Skin Cancer, Thyroid Cancer, Thymus Cancer.
How does it
Work
The TruCheck™ Early Cancer Screening blood test is a non-invasive blood test that checks for the existence of cancer or tumour cells in the blood; The type of cancer is identified, as well as the organ of origin.
The TruCheck™ Early Cancer Screening blood test is only available to those over 35 years old.
Enquire about your test
Initial
Consultation
We will arrange an initial consultation to discuss your medical history and explain the risks and benefits associated with the test. Your blood sample will be taken and sent to the laboratory for examination.
Receiving your
Results
You will usually receive your results within 2-3 weeks of the laboratory having received your sample. We will arrange a subsequent appointment to review your results and discuss any further treatment if required.
Check For?
What does the test
The test will detect whether you have cancer or not, as well as the location of any tumours
• Melanoma • Head and Neck • Salivary Gland • Thyroid, Lung, Breast • Liver • Biliary Tract • Gastrointestinal • Soft Tissue • Osteosarcomas • Mesothelioma • Urinary Tract • Gynaecological • Prostate • Thymus • Adrenal • Central Nervous System
-
Adenocarcinoma – Salivary Duct, Thyroid, Breast, lung, Oesophagus, Stomach, Duodenum, Jejunum, Ileum, Colon, Rectum, Pancreas, Gallbladder, Bile Duct, Liver, Ovary, Prostate, Uterus
-
Squamous Cell Carcinoma – Buccal Mucosa, Hard Palate, Larynx, Lip, Oral Cavity, Paranasal Sinus, Pharynx, Pyriform Fossa, Retromolar Trigone, Soft palate, Tongue, Tonsil, Oesophagus, Lung, Penis, Cervix, Vulva, Vagina, Anorectal, Skin.
-
Adenosquamous Carcinoma – Oesophagus, Lung
-
Neuroendocrine – Lung, Oesophagus, Duodenum, Jejunum, lleum, Thymus, Adrenal, Pancreas, Prostate, Colon, Rectum
-
Renal Cell Carcinoma – Kidney
-
Transitional Cell Carcinoma – Bladder, Renal Pelvis, Ureter
-
Gastrointestinal Stromal tumours – Stomach, Duodenum, Ileum, Jejunum, Colon, Rectum
-
Melanomas – Cutaneous, Mucosal
Price: £1,199
New to the screening industry, the TruCheck Test was launched in 2022 after rigorous clinical trials. It is the only test available publicly to check for Circulating Tumour Cells (CTCs), detecting even the tiniest existence of cancer from a small blood sample.
Highly accurate, it not only identifies whether you have CTCs, but also where they originated. This means you know where in your body the primary tumour is located, speeding up diagnosis and treatment, and enabling doctors to focus on the required areas.
THE SENSITIVITY OF THIS TEST IS 88%, WHICH MEANS THAT IT WILL CORRECTLY DETECT 88 OUT OF 100 PEOPLE WITH ANY EARLY SIGNS OF CANCER. THE TEST HAS BEEN VALIDATED ON A COHORT OF OVER 40,000 PARTICIPANTS AND DISPLAYS A 96% ACCURACY IN DETERMINING THE ORIGIN OF THE CANCER, IN POSITIVE CASES.
